Various immune cells and secreted cytokines play pivotal roles in tumor initiation, progression, metastasis, and also influence the therapeutic outcomes of anti-PD-1/PD-L1 treatments, offering hope to patients with diverse tumor types. This evidence concerns the gene CD274 and neoplasm.